Work

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic

Year: 2008
Type: review
Abstract: Thrombolysis with tissue-type plasminogen activator (tPA) is used for the treatment of patients with acute ischemic stroke. However, a growing body of evidence indicates that, besides the unquestionable benefit from its thrombolytic activity, tPA also has a deleterious effect on the ischemic brain including cytotoxicity and increased permeability of the neurovascular unit with the development of cerebral edema. Because an increasing number of acute stroke patients are treated with tPA, it is important to know the mechanisms of harmful effects of tPA on the ischemic brain. Here, the best studied pathways of tPA neurotoxicity are discussed along with future directions for a safer use of tPA as a thrombolytic agent in the setting of acute ischemic stroke.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $7,030
OpenAlex ID: W1980074181
FWCI: 2.991
Cites: 80
Cited by: 295
Related to: 10